X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73) 73
medicine, general & internal (61) 61
internal medicine (52) 52
female (47) 47
medicine & public health (45) 45
index medicus (41) 41
medicine/public health, general (41) 41
endocrinology (40) 40
male (40) 40
gastroenterology (39) 39
pneumology/respiratory system (39) 39
adult (29) 29
middle aged (29) 29
endocrinology & metabolism (27) 27
austria (22) 22
metaanalysis (20) 20
aged (19) 19
practice guidelines as topic (19) 19
pregnancy (18) 18
diabetes (17) 17
risk (17) 17
type 2 diabetes (16) 16
diabetes mellitus (15) 15
insulin (14) 14
prevention (14) 14
treatment outcome (14) 14
diabetes mellitus, type 2 - blood (13) 13
blood glucose - metabolism (12) 12
glucose (12) 12
hypoglycemia (12) 12
hypoglycemic agents - administration & dosage (12) 12
insulin - administration & dosage (12) 12
mellitus (12) 12
risk factors (12) 12
women (12) 12
glucose control (11) 11
hypoglycemic agents - therapeutic use (11) 11
outcomes (11) 11
complications (10) 10
diabetes mellitus, type 2 - drug therapy (10) 10
glycemic control (10) 10
hyperglycemia (10) 10
adults (9) 9
analysis (9) 9
animals (9) 9
blood glucose - analysis (9) 9
diabetes education (9) 9
diabetes mellitus, type 2 - diagnosis (9) 9
drug administration schedule (9) 9
evidence-based medicine (9) 9
diabetes mellitus, type 1 - blood (8) 8
diabetes mellitus, type 2 - therapy (8) 8
insulin therapy (8) 8
therapy (8) 8
adolescent (7) 7
body mass index (7) 7
care and treatment (7) 7
dextrose (7) 7
diabetes therapy (7) 7
insulin - therapeutic use (7) 7
prevalence (7) 7
rats (7) 7
time factors (7) 7
austria - epidemiology (6) 6
blood-glucose (6) 6
cardiovascular risk (6) 6
case-control studies (6) 6
critically ill (6) 6
diabetes mellitus type 2 (6) 6
diabetes mellitus, type 1 - drug therapy (6) 6
diabetic complications (6) 6
diabetic embryopathy (6) 6
diabetic fetopathy (6) 6
dose-response relationship, drug (6) 6
exercise (6) 6
glucose lowering (6) 6
glycated hemoglobin a - analysis (6) 6
glycated hemoglobin a - metabolism (6) 6
infant, newborn (6) 6
intensive insulin therapy (6) 6
medicine (6) 6
myocardial-infarction (6) 6
reference values (6) 6
research (6) 6
risk-factors (6) 6
surgery (6) 6
type 1 diabetes (6) 6
type 1 diabetes mellitus (6) 6
type 2 diabetes mellitus (6) 6
aged, 80 and over (5) 5
blood sugar monitoring (5) 5
cardiovascular-disease (5) 5
cholesterol (5) 5
diabetes mellitus, type 2 - epidemiology (5) 5
diabetes mellitus, type 2 - prevention & control (5) 5
diabetes, gestational - blood (5) 5
diabetes, gestational - diagnosis (5) 5
follow-up studies (5) 5
genetic aspects (5) 5
gestational diabetes (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Olsson, J and Stang, P and Emslie-Smith, A and Boyle, D I. R and Evans, J M. M and Macdonald, T M and Bain, J and Juhl, C and Sturis, J and Hollingdal, M and Pincus, S and Veldhuis, J and Dejgaard, A and Schmitz, O and Frandsen, K B and Bayer, Th and Dunning, B E and Grunberger, G and Rappaport, E B and Sargeant, L A and Khaw, K T and Lithell, Hans and Hales, C Nicholas and Berne, Christian and Oksanen, L and Tuomainen, T.-P and Kontula, K and Dekker, J M and de Boks, P and de Vegt, F and Nijpels, G and Bruno, G and Cavallo-Perin, P and Bargero, G and D’Errico, N and Borra, M and Macchia, G and Pagano, G and Newton, R W and New, J P and Roxburgh, M A and Elliott, P and Brennan, G and Devers, M and MacAlpine, R and Steinke, D and Decallonne, B and Casteels, K and Bouillon, R and Mathieu, C and Linn, Thomas and Strate, Christine and Jirsa Jr, M and Kozáková, H and Kaas, A and Tlaskalová-Hogenová, H and Wanka, H and Hartmann, A and Kuttler, B and Sørensen, T S and Markholst, H and Petersen, J S and Karounos, D and Dyrberg, T and Mabley, J G and Haskó, G and Seissler, J and Nguyen, T B. T and Sensi, M and Guidobaldi, L and Pantellini, F and Cerrito, M G and Scarpa, S and Di Mario, U and Morano, S and Ceolotto, G and Baritono, E and Del Prato, S and Semplicini, A and Zerbini, G and Tentori, F and Maestroni, A and Mangili, R and Tiengo, A and Tadjieva, J and Mankovsky, B N and Van Aken, S and Raes, A and Vande Walle, J and Matthys, D and Lund, S S and Andersen, S and Hansen, B V and Trautner, C and Willich, S and Tabák, Á Gy and Orchard, T J and Spranger, J and Preissner, K T and Schatz, H and ... and IMDIAB Study Group and Osaka IDDM Study Group and European Group for the Study of Insulin Resistance (EGIR) and Screen-Pol Study Group and Northern Diabetic Pregnancy Survey and Brazilian Gestational Diabetes Study Group and UK Prospective Diabetes Study Group and Hungarian HbA1c Screening Study Group and Croatian Study Group for Diabetic Amyotrophy and EURODIAB IDDM Study Group and Neuropathy Study Group of the Italian Society of the Study of Diabetes and Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and HOE 901/3003 study group and German Working Group on Quality Control and Turkish Diabetes Epidemiology Group and Mauritian NCD group and D.I.O.R. study group and Lithuanian Collaborative Group for the Epidemiology of Diabetes and DARTS/MEMO Collaboration and Cerivastatin/Bezafibrate Latin America Study Group and Pramlintide Type 1 Study Group and Non-Invasive Task Force and Childhood Diabetes in Finland Study Group and German Pediat. Working Group and EURODIAB Complications Study Group and Hvidøre Study group on Childhood Diabetes and EURODIAB Prospective Complications Study (PCS) Group and WHO/IDF Patient Empowerment Workshop and AD Morris for the DARTS/MEMO Collaboration and Pramlintide Type 2 Study Group and Finnish Diabetes Prevention Study Group and Service of internal medecine - diabetologia - vascular diseases and UKPDS Group and IGT Research Group and DAIS Project Group and KANWU study group and Cerivastatin Combination Therapy Study Group and GENEDIAB Study Group and TARDIS Steering Committee and UK centres and Rosiglitazone Study Group and GEDEC study group and HIDM investigators and US Study Group of Insulin Glargine in Type 2 DM and European Insulin Aspart Study Group and The TARDIS Steering Committee and UK centres and The Turkish Diabetes Epidemiology Group and The EURODIAB Prospective Complications Study (PCS) Group and The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and The Finnish Diabetes Prevention Study Group
Diabetologia, ISSN 0012-186X, 8/1999, Volume 42, Issue S1, pp. A1 - A330
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2012, Volume 98, Issue 1, pp. 5 - 10
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 04/2018, Volume 138, pp. 193 - 200
•Flash monitoring is affordable in UK patients with T1DM using intensive insulin.•Costs of flash monitoring may be offset by reductions in severe... 
Calculation | Diabetes | Flash | Hypoglycaemia | Cost | Monitoring | IMPACT | SEVERE HYPOGLYCEMIA | BLOOD-GLUCOSE | ENDOCRINOLOGY & METABOLISM | PEOPLE | Medical testing products | Blood sugar monitoring | Blood sugar | Type 1 diabetes | Patient monitoring equipment | Analysis | Insulin | Diabetes therapy
Journal Article
Diabetologia, ISSN 0012-186X, 3/2018, Volume 61, Issue 3, pp. 539 - 550
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10077, pp. 1396 - 1397
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)30893-0 Byline: Jan Bolinder (a), Ramiro Antuna (b),... 
Internal Medicine | Blood Glucose | Skin | Administration, Cutaneous | Blood Glucose Self-Monitoring - adverse effects | Humans | Medical colleges | Medical equipment | Side effects | Adhesives | Diabetes | Monitoring systems | Sensors
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2016, Volume 18, Issue 5, pp. 475 - 482
Aims To evaluate the safety and efficacy of once‐weekly dulaglutide 1.5 mg, a long‐acting glucagon‐like peptide‐1 receptor agonist, compared with placebo in... 
glucagon‐like peptide‐1 | type 2 diabetes | dulaglutide | Type 2 diabetes | Dulaglutide | Glucagon-like peptide-1 | METFORMIN | GLYCEMIC CONTROL | SULFONYLUREA | glucagon-like peptide-1 | EXENATIDE | SITAGLIPTIN | OPEN-LABEL | TREATED PATIENTS | LIRAGLUTIDE | PARALLEL-GROUP | ENDOCRINOLOGY & METABOLISM | ASSOCIATION | Glycated Hemoglobin A - analysis | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Diabetes Mellitus, Type 2 - metabolism | Patient Dropouts | Immunoglobulin Fc Fragments - administration & dosage | Hypoglycemia - prevention & control | Drug Therapy, Combination - adverse effects | Glucagon-Like Peptide-1 Receptor - metabolism | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Female | Immunoglobulin Fc Fragments - therapeutic use | Hypoglycemia - chemically induced | Glucagon-Like Peptides - analogs & derivatives | Drug Resistance | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Double-Blind Method | Drug Administration Schedule | Sulfonylurea Compounds - therapeutic use | Sulfonylurea Compounds - adverse effects | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Intention to Treat Analysis | Aged | Glucagon-Like Peptides - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Glycosylated hemoglobin | Glimepiride | Glucose | Glucagon | Dextrose | Confidence intervals | Hypoglycemia | Diabetes | Motivation | Diabetes mellitus | Hemoglobin | Diarrhea | Nausea | Safety | Glucagon-like peptide 1 | Original
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, p. e16455
Journal Article